2023
Genital tuberculosis, infertility and assisted reproduction
Mir N, Pal L. Genital tuberculosis, infertility and assisted reproduction. Current Opinion In Obstetrics & Gynecology 2023, 35: 263-269. PMID: 36912346, DOI: 10.1097/gco.0000000000000866.Peer-Reviewed Original ResearchMeSH KeywordsFemaleFertilization in VitroHumansInfertilityInfertility, FemaleReproductionReproductive Techniques, AssistedTuberculosis, Female GenitalConceptsGenital tuberculosisClinical presentationLife-threatening risksGenital TBFetal morbidityInfertile womenCouple infertilityAppropriate screeningTimely treatmentRisk populationsUntreated casesInfertilityAssisted reproductionReproductive technologiesUnique risksTuberculosisRiskPresentationMorbidityIVFEpidemiologyDiagnosisRecent literatureWomen
2022
Follicle-stimulating hormone (and luteinizing hormone) in ovarian stimulation: Does the dose matter for cycle success?
Kuokkanen S, Pal L. Follicle-stimulating hormone (and luteinizing hormone) in ovarian stimulation: Does the dose matter for cycle success? Fertility And Sterility 2022, 119: 166-169. PMID: 36529184, DOI: 10.1016/j.fertnstert.2022.12.019.Peer-Reviewed Original Research
2008
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization
Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertility And Sterility 2008, 89: 1694-1701. PMID: 18440515, PMCID: PMC2601677, DOI: 10.1016/j.fertnstert.2007.05.055.Peer-Reviewed Original ResearchConceptsNondonor IVF cyclesClinical pregnancyCycle cancellationLive birthsGonadotropin useIVF cyclesSpontaneous miscarriageOvarian reserve statusOvarian hyperstimulation resultsHigh gonadotropinsOvarian stimulationFertilization cyclesIVF outcomesOocyte yieldWorse prognosisRetrospective studyIVF centerImproved outcomesAggressive approachMAIN OUTCOMEPregnancyIVFHigher likelihoodBirthOutcomes
2004
Postthaw blastomere survival is predictive of the success of frozen–Thawed embryo transfer cycles
Pal L, Kovacs P, Witt B, Jindal S, Santoro N, Barad D. Postthaw blastomere survival is predictive of the success of frozen–Thawed embryo transfer cycles. Fertility And Sterility 2004, 82: 821-826. PMID: 15482754, DOI: 10.1016/j.fertnstert.2004.02.136.Peer-Reviewed Original ResearchConceptsEmbryo transfer cyclesFET cyclesBlastomere survivalImplantation rateTransfer cyclesFrozen-thawed embryo transfer cyclesClinical pregnancy rateTertiary care facilitySerum P levelsClinical pregnancyHCG administrationInfertile womenRetrospective studyInverse associationIVF unitPregnancy rateMAIN OUTCOMECare facilitiesPregnancySurvivalOutcomesEmbryo survivalLower survivalHigher survivalAdministration
1999
Effect of a baseline ovarian cyst on the outcome of in vitro fertilization–embryo transfer
Segal S, Shifren J, Isaacson K, Leykin L, Chang Y, Pal L, Toth T. Effect of a baseline ovarian cyst on the outcome of in vitro fertilization–embryo transfer. Fertility And Sterility 1999, 71: 274-277. PMID: 9988397, DOI: 10.1016/s0015-0282(98)00449-x.Peer-Reviewed Original ResearchConceptsBaseline ovarian cystsOvarian cystsHCG administrationE2 levelsPregnancy rateDay 3Cycle day 3Fertilization-embryo transferOutcome of IVFNumber of folliclesNumber of oocytesNumber of embryosBaseline cystOvarian hyperstimulationIVF-ETPoor outcomeRetrospective studyUltrasound examinationMAIN OUTCOMEAcademic centersFertilization unitCystsPatientsMature oocytesOutcomes
1998
Malignancy may adversely influence the quality and behaviour of oocytes.
Pal L, Leykin L, Schifren J, Isaacson K, Chang Y, Nikruil N, Chen Z, Toth T. Malignancy may adversely influence the quality and behaviour of oocytes. Human Reproduction 1998, 13: 1837-1840. PMID: 9740435, DOI: 10.1093/humrep/13.7.1837.Peer-Reviewed Original ResearchConceptsMalignant diseaseMalignant disordersAge-matched patientsCell of originTubal infertilityIVF cyclesOvarian stimulationDefinitive treatmentCase seriesCertain malignanciesNeoplastic processPatientsComparable total numberMature oocytesMalignancyFertilization rateDiseasePotential fertilityApparent adverse influenceOocytesPoor qualityDisordersTotal numberAdverse influenceInfertilityImpact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization–Embryo Transfer
Pal L, Shifren J, Isaacson K, Chang Y, Leykin L, Toth T. Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization–Embryo Transfer. Journal Of Assisted Reproduction And Genetics 1998, 15: 27-31. PMID: 9493063, PMCID: PMC3468198, DOI: 10.1023/a:1022574221115.Peer-Reviewed Original ResearchConceptsSeverity of endometriosisMale factor infertilityIVF cyclesIVF-ETGroup BGroup AIVF-embryo transfer cyclesVitro Fertilization-Embryo TransferAmerican Fertility Society classificationGonadotropin-releasing hormone agonistAcademic IVF programDay 3 follicleHuman menopausal gonadotropinCycles of IVFFertilization-embryo transferIU/LCombination of FSHOocytes of patientsSeverity of diseaseQuality of oocytesImpact of severityMenopausal gonadotropinOvarian hyperstimulationAdvanced diseaseClinical pregnancy
1997
Outcome of IVF in DES-Exposed Daughters: Experience in the 90s
Pal L, Shifren J, Isaacson K, Chang Y, Marean M, Leykin L, Toth T. Outcome of IVF in DES-Exposed Daughters: Experience in the 90s. Journal Of Assisted Reproduction And Genetics 1997, 14: 513-517. PMID: 9401869, PMCID: PMC3454843, DOI: 10.1023/a:1021175326230.Peer-Reviewed Original ResearchConceptsMassachusetts General HospitalOngoing pregnancy rateOutcome of IVFIVF cyclesInfertile womenUtero exposurePregnancy rateAcademic IVF programDay 3 levelsOutcome of ARTSelf-reported historyQuality of embryosOvarian hyperstimulationUtero DiethylstilbestrolControl patientsIdiopathic infertilitySerum estradiolImplantation rateInfertile patientsIVF programGeneral HospitalIVF unitEmbryo transferPatientsLow implantation